Cargando…

P-glycoprotein and metallothionein expression and resistance to chemotherapy in osteosarcoma.

The expression of the drug resistance (DR) mediators P-glycoprotein (P-gp) and the metallothioneins (MT) was assessed immunohistochemically in biopsy material from patients with high-grade malignant osteosarcoma (OS). No significant difference was found in survival rate between expressors of both P-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shnyder, S. D., Hayes, A. J., Pringle, J., Archer, C. W.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group\|1 1998
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062957/ https://www.ncbi.nlm.nih.gov/pubmed/9743295

Ejemplares similares

Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance
por: Habel, N, et al.
Publicado: (2013)

Metallothionein levels in ovarian tumours before and after chemotherapy.
por: Murphy, D., et al.
Publicado: (1991)

Metallothionein expression in human breast cancer.
por: Goulding, H., et al.
Publicado: (1995)

Osteoblastic differentiation and P-glycoprotein multidrug resistance in a murine osteosarcoma model
por: Takeshita, H, et al.
Publicado: (2000)

P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy.
por: Dixon, A. R., et al.
Publicado: (1992)

P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseases
por: Yoshimori, Mayumi, et al.
Publicado: (2015)

Structure of mammalian metallothionein.
por: Kägi, J H, et al.
Publicado: (1984)

Pleiotrophin promotes chemoresistance to doxorubicin in osteosarcoma by upregulating P-glycoprotein
por: Wu, Dapeng, et al.
Publicado: (2017)

High expression of ABCG2 is associated with chemotherapy resistance of osteosarcoma
por: Shu, Hao, et al.
Publicado: (2021)

Mechanism of multidrug resistance to chemotherapy mediated by P-glycoprotein (Review)
por: Tian, Yichen, et al.
Publicado: (2023)

Anti-metallothionein IgG and levels of metallothionein in autistic children with GI disease
por: Russo, A J
Publicado: (2009)

In vitro and in vivo studies on the degradation of metallothionein.
por: Klaassen, C D, et al.
Publicado: (1994)

Gene expression array profile of human osteosarcoma
por: Leonard, P, et al.
Publicado: (2003)

Crystals of cadmium, zinc metallothionein.
por: Melis, K A, et al.
Publicado: (1984)

Correlation of metallothionein expression with apoptosis in nasopharyngeal carcinoma
por: Jayasurya, A, et al.
Publicado: (2000)

Expression, purification of metallothionein genes from freshwater crab (Sinopotamon yangtsekiense) and development of an anti-metallothionein ELISA
por: Yang, Jian, et al.
Publicado: (2017)

Metallothionein expression in feline injection site fibrosarcomas
por: Mikiewicz, Mateusz, et al.
Publicado: (2023)

Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy
por: Mairinger, Fabian D., et al.
Publicado: (2018)

Effects of different levels of TGF-β expression and tumor cell necrosis rates in osteosarcoma on the chemotherapy resistance of osteosarcoma
por: Zhou, Ling, et al.
Publicado: (2020)

The human metallothionein gene family: structure and expression.
por: Karin, M, et al.
Publicado: (1984)

Association of metallothionein expression and clinical response to cisplatin based chemotherapy in testicular germ cell tumors
por: Tuzel, Emre, et al.
Publicado: (2015)

NMR studies of crab and plaice metallothioneins.
por: Higham, D P, et al.
Publicado: (1986)

Chemotherapy for osteosarcoma.
por: Souhami, R. L.
Publicado: (1989)

BMI1 Is Expressed in Canine Osteosarcoma and Contributes to Cell Growth and Chemotherapy Resistance
por: Shahi, Mehdi Hayat, et al.
Publicado: (2015)

Hepatic Expression of Metallothionein I/II, Glycoprotein 96, IL-6, and TGF-β in Rat Strains with Different Susceptibilities to Experimental Autoimmune Encephalomyelitis
por: Grubić-Kezele, Tanja, et al.
Publicado: (2013)

Prognostic significance of metallothionein expression in renal cell carcinoma
por: Mitropoulos, Dionisios, et al.
Publicado: (2005)

Diurnal-and sex-related difference of metallothionein expression in mice
por: Zhang, Dan, et al.
Publicado: (2012)

Expression of Metallothioneins in Cutaneous Squamous Cell Carcinoma and Actinic Keratosis
por: Zamirska, Aleksandra, et al.
Publicado: (2012)

Anlotinib Reverses Multidrug Resistance (MDR) in Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function In Vitro and In Vivo
por: Wang, Gangyang, et al.
Publicado: (2022)

Metallothionein gene expression in renal cell carcinoma
por: Pal, Deeksha, et al.
Publicado: (2014)

Elevated metallothionein expression in long-lived species
por: Malavolta, Marco, et al.
Publicado: (2022)

An overview of resistance to chemotherapy in osteosarcoma and future perspectives
por: Garcia-Ortega, Dorian Yarih, et al.
Publicado: (2022)

Metallothionein mediates leukocyte chemotaxis
por: Yin, Xiuyun, et al.
Publicado: (2005)

Promiscuity and preferences of metallothioneins: the cell rules
por: Foster, Andrew W, et al.
Publicado: (2011)

Physiological and chemical characterization of cyanobacterial metallothioneins.
por: Olafson, R W
Publicado: (1986)

ERBB and P‐glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P‐glycoprotein
por: Rösch, Lisa, et al.
Publicado: (2022)

Metallothionein 3 Expression in Normal Skin and Malignant Skin Lesions
por: Pula, Bartosz, et al.
Publicado: (2014)

The roles of metallothioneins in carcinogenesis
por: Si, Manfei, et al.
Publicado: (2018)

Metallothionein in Brain Disorders
por: Juárez-Rebollar, Daniel, et al.
Publicado: (2017)

CPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated protein.
por: Jansen, W. J., et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_l4ut88i1midhblvp3h6a7c5fv3